MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-10-24, MDT made $8,961M in revenue. $1,374M in net income. Net profit margin of 15.33%.

Income Overview

Revenue
$8,961M
Net Income
$1,374M
Net Profit Margin
15.33%
EPS
$1.07
Unit: Million (M) dollars
Revenue Breakdown
    • Neuroscience Group
    • Medical Surgical
    • Medical Surgical-Surgical Endosc...
    • Others
Revenue Breakdown
    • Cardiovascular
    • Neuroscience Group
    • Medical Surgical
    • Others
Revenue Breakdown
    • US
    • Total Other Countries Excluding ...
    • IE

Income Statement
2025-10-24
2025-07-25
2025-04-25
2025-01-24
Net sales
8,961 8,578 8,927 8,292
Cost of products sold, excluding amortization of intangible assets
3,061 3,001 3,146 2,779
Research and development expense
754 726 684 675
Selling, general, and administrative expense
2,965 2,806 2,720 2,717
Amortization of intangible assets
463 459 564 416
Restructuring charges, net
10 45 147 43
Certain litigation charges, net
0 27 214 22
Other operating expense (income), net
-22 -70 -15 5
Operating profit
1,686 1,445 1,436 1,646
Other non-operating income, net
92 33 0 72
Interest expense, net
181 176 174 179
Income before income taxes
1,597 1,302 1,261 1,540
Income tax provision
215 255 198 237
Net income
1,381 1,047 1,061 1,303
Net income attributable to noncontrolling interests
7 7 5 9
Net income attributable to medtronic
1,374 1,040 1,056 1,294
Basic EPS
1.07 0.81 0.822 1.01
Diluted EPS
1.07 0.81 0.819 1.01
Basic Average Shares
1,282,000,000 1,281,600,000 1,284,300,000 1,282,400,000
Diluted Average Shares
1,288,000,000 1,287,100,000 1,290,000,000 1,286,200,000
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Neuroscience Group$2,562M (4.53%↑ Y/Y)Medical Surgical$2,171M (2.02%↑ Y/Y)MedicalSurgical-Surgical Endoscopy$1,679M (1.82%↑ Y/Y)Diabetes Group$757M (10.35%↑ Y/Y)NeuroscienceGroup-Specialty Therapies...$744M (0.95%↑ Y/Y)NeuromodulationDivision-Neuroscience Group$520M (8.33%↑ Y/Y)Acute CareMonitoring-Medical Surgical$493M (3.14%↑ Y/Y)Total ReportableSegments$8,926M (6.69%↑ Y/Y)All Other Segments$35M (-5.41%↓ Y/Y)Net sales$8,961M (6.64%↑ Y/Y)Operating profit$1,686M (5.71%↑ Y/Y)Other non-operatingincome, net$92M (-46.82%↓ Y/Y)Cost of productssold, excluding...$3,061M (3.90%↑ Y/Y)Selling, general, andadministrative expense$2,965M (7.54%↑ Y/Y)Research and developmentexpense$754M (8.18%↑ Y/Y)Amortization of intangibleassets$463M (12.11%↑ Y/Y)Other operatingexpense (income), net-$22M (-164.71%↓ Y/Y)Restructuring charges, net$10M (-66.67%↓ Y/Y)Income before incometaxes$1,597M (2.44%↑ Y/Y)Interest expense, net$181M (-13.40%↓ Y/Y)Net income$1,381M (8.06%↑ Y/Y)Income tax provision$215M (-23.49%↓ Y/Y)Net incomeattributable to medtronic$1,374M (8.19%↑ Y/Y)Net incomeattributable to...$7M (-22.22%↓ Y/Y)

Medtronic_logo-svg (2)-svg

Medtronic plc (MDT)

Medtronic_logo-svg (2)-svg

Medtronic plc (MDT)